Patient factors associated with chemotherapy modifications: Results from the Optimal Breast Cancer Chemotherapy Dosing (OBCD) study Meeting Abstract


Authors: Kantor, E.; Bhimani, J.; Gallagher, G. B.; Blinder, V. S.; Burganowski, R. P.; Griggs, J. J.; Kolevska, T.; Kroenke, C.; Laurent, C.; Liu, R.; Nakata, K. G.; O'Connell, K.; Persaud, S.; Rivera, D.; Roh, J. M.; Valice, E.; Wang, P.; Bandera, E. V.; Bowles, E. A.; Kushi, L. H.
Abstract Title: Patient factors associated with chemotherapy modifications: Results from the Optimal Breast Cancer Chemotherapy Dosing (OBCD) study
Meeting Title: 2024 ASCO Annual Meeting
Journal Title: Journal of Clinical Oncology
Volume: 42
Issue: 16 Suppl.
Meeting Dates: 2024 May 31-Jun 4
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2024-06-01
Language: English
ACCESSION: WOS:001275557400023
PROVIDER: wos
DOI: 10.1200/JCO.2024.42.16_suppl.520
Notes: Meeting Abstract: 520 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Victoria Susana Blinder
    111 Blinder
  2. Elizabeth David Kantor
    40 Kantor
  3. Jenna Bhimani
    14 Bhimani
  4. Sonia Persaud
    21 Persaud
  5. Peng Wang
    6 Wang
Related MSK Work